Regulatory and scientific virtual conference on RNA-based medicines
Table of contents
Date:
02/02/2023
Location:
Online, 09:00 - 16:30 Amsterdam time (CET)
The aim of the conference is to promote the development of RNA-based medicines by:
- Identifying scientific and regulatory opportunities and challenges of RNA-based innovative medicines;
- Facilitating dialogue between industry/academia and regulators and raising awareness on scientific and regulatory aspects;
- Identifying gaps in regulatory science.
This initiative addresses Goal 1 (catalysing the integration of science and technology in medicines development) of the EMA Regulatory Science Strategy to 2025.
The conference focuses on emerging RNA technologies beyond vaccines.
RNA for gene editing and primary prevention of infectious diseases is not within the scope of this event.
-
List item
Report - Regulatory and scientific virtual conference on RNA-based medicines (PDF/320.12 KB)
First published: 24/02/2023 -
List item
Agenda - Regulatory and scientific virtual conference on RNA-based medicines (PDF/523.98 KB)
First published: 09/12/2022
Last updated: 09/02/2023 -
List item
Speakers’ biography (PDF/569.94 KB)
First published: 08/02/2023 -
List item
Presentation - State of the Art of RNA Technologies_EU regulators’ perspective (Sol Ruiz) (PDF/11.79 MB)
First published: 08/02/2023 -
List item
Presentation - A brief introduction into oligonucleotide therapies (Annemieke Aartsma-Rus) (PDF/923.16 KB)
First published: 08/02/2023 -
List item
Presentation - State of the Art of RNA Technologies "Industry Perspective" (Tal Zaks) (PDF/1.36 MB)
First published: 08/02/2023 -
List item
Presentation - EU Regulators’ experience with synthetic oligonucleotides and mRNA technology (René Thürmer) (PDF/993.92 KB)
First published: 08/02/2023 -
List item
Presentation - Industry perspective on synthetic oligonucleotide (Daniel Capaldi) (PDF/1.18 MB)
First published: 08/02/2023 -
List item
Presentation - Industry perspective on mRNA technology (Pawel Widomski) (PDF/9.86 MB)
First published: 08/02/2023 -
List item
Presentation - Opportunities and challenges in non-clinical development - Academic Perspective (Haiyan Zhou) (PDF/1.42 MB)
First published: 08/02/2023 -
List item
Presentation - Application of RNA Technologies Non-Clinical Industry perspective (Susan Goody) (PDF/921.99 KB)
First published: 08/02/2023 -
List item
Presentation - Opportunities and challenges in non-clinical development - The regulator's perspective (Camilla Svensson) (PDF/681.23 KB)
First published: 08/02/2023 -
List item
Presentation - Applications of RNA technologies - Clinical_Academia perspective (David Henshall) (PDF/2.49 MB)
First published: 08/02/2023 -
List item
Presentation - Applications of RNA technologies - Clinical - An Industry Perspective (Michael Wenger) (PDF/478.6 KB)
First published: 08/02/2023 -
List item
Presentation - Applications of RNA technologies - Clinical - Regulators' perspective (Joop van Gerven) (PDF/314.86 KB)
First published: 08/02/2023